Neurociencia Traslacional

Artigos Científicos

• Amoretti S, Verdolini N, Mezquida G, Rabelo-da-Ponte FD, Cuesta MJ, Pina-Camacho L, Gomez-Ramiro M, De-la-Cámara C, González-Pinto A, Díaz-Caneja CM, Corripio I, Vieta E, de la Serna E, Mané A, Solé B, Carvalho AF, Serra M, Bernardo M. Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique. Eur Neuropsychopharmacol. 2021 Jun;47:112-129. doi: 10.1016/j.euroneuro.2021.01.095. Epub 2021 Jan 30. PubMed PMID: 33531261. +Pubmed +DOI
• Baldaquí N, Anmella G, Gómez-Ramiro M, Guasp M, Mesa A, Parellada E. Thyrotoxic Psychosis Associated With Amiodarone. J Clin Psychopharmacol. 2021 May-Jun 01;41(3):342-344. doi: 10.1097/JCP.0000000000001375. PubMed PMID: 33734169. +Pubmed +DOI
• Borrajo A, Spuch C, Penedo MA, Olivares JM, Agís-Balboa RC. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis. Ann Med. 2021 Dec;53(1):43-69. doi: 10.1080/07853890.2020.1814962. Epub 2020 Sep 17. Review. PubMed PMID: 32841065; PubMed Central PMCID: PMC7877929. +Pubmed +DOI
• Borrajo A, Spuch C, Penedo MA, Olivares JM, Agís-Balboa RC. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis. Ann Med. 2021;53(1):43–69. PMID: 32841065. DOI: 10.1080/07853890.2020.1814962. http://www.ncbi.nlm.nih.gov/pubmed/32841065 +Pubmed +DOI
• Borrajo López A, Penedo MA, Rivera-Baltanas T, Pérez-Rodríguez D, Alonso-Crespo D, Fernández-Pereira C, Olivares JM, Agís-Balboa RC. Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders? Biomedicines. 2021 Jul 30;9(8). pii: 925. doi: 10.3390/biomedicines9080925. Review. PubMed PMID: 34440127; PubMed Central PMCID: PMC8389599. +Pubmed +DOI
• Borrajo López A, Penedo MA, Rivera-Baltanas T, Pérez-Rodríguez D, Alonso-Crespo D, Fernández-Pereira C, Olivares JM, Agís-Balboa RC. Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders? Biomedicines. 2021 Jul;9(8):925. DOI: 10.3390/biomedicines9080925. https://www.mdpi.com/2227-9059/9/8/925 +DOI
• Borrajo López A, Penedo MA, Rivera-Baltanas T, Pérez-Rodríguez D, Alonso-Crespo D, Fernández-Pereira C, Olivares JM, Agís-Balboa RC. Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders? Biomedicines. 2021 Jul;9(8):925. DOI: 10.3390/biomedicines9080925. https://www.mdpi.com/2227-9059/9/8/925 +DOI
• Catalan A, García L, Sanchez-Alonso S, Gil P, Díaz-Marsá M, Olivares JM, Rivera-Baltanás T, Pérez-Martín J, Torres MÁG, Ovejero S, Tost M, Bergé D, Rodríguez A, Labad J. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis. Early Interv Psychiatry. 2021 Dec;15(6):1584–94. PMID: 33289317. DOI: 10.1111/eip.13098. http://www.ncbi.nlm.nih.gov/pubmed/33289317 +Pubmed +DOI
• Catalan A, García L, Sanchez-Alonso S, Gil P, Díaz-Marsá M, Olivares JM, Rivera-Baltanás T, Pérez-Martín J, Torres MÁG, Ovejero S, Tost M, Bergé D, Rodríguez A, Labad J. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis. Early Interv Psychiatry. 2021 Dec;15(6):1584–94. PMID: 33289317. DOI: 10.1111/eip.13098. http://www.ncbi.nlm.nih.gov/pubmed/33289317 +Pubmed +DOI
• Coelho-Guimarães N, Garcia-Casal JA, Díaz-Mosquera S, Álvarez-Ariza M, Martínez-Abad F, Mateos-Álvarez R. [Validation of RUDAS: A screening tool for dementia in Primary Health Care settings]. Aten Primaria. 2021 May;53(5):102024. doi: 10.1016/j.aprim.2021.102024. Epub 2021 Mar 31. Spanish. PubMed PMID: 33812318; PubMed Central PMCID: PMC8050365. +Pubmed +DOI
• Coelho-Guimarães N, Garcia-Casal JA, Díaz-Mosquera S, Álvarez-Ariza M, Martínez-Abad F, Mateos-Álvarez R. [Validation of RUDAS: A screening tool for dementia in Primary Health Care settings]. Aten primaria. 2021;53(5):102024. PMID: 33812318. DOI: 10.1016/j.aprim.2021.102024. http://www.ncbi.nlm.nih.gov/pubmed/33812318 +Pubmed +DOI
• Fernández-Velasco JI, Kuhle J, Monreal E, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Sánchez P, Carreón-Guarnizo E, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, Masjuan J, Costa-Frossard L, Villar LM. Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS. Neurol Neuroimmunol neuroinflammation. 2021;8(2):e940. PMID: 33408167. DOI: 10.1212/NXI.0000000000000940. http://www.ncbi.nlm.nih.gov/pubmed/33408167 +Pubmed +DOI
• Fernández-Velasco JI, Kuhle J, Monreal E, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Sánchez P, Carreón-Guarnizo E, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, Masjuan J, Costa-Frossard L, Villar LM. Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS. Neurol Neuroimmunol neuroinflammation. 2021;8(2):e940. PMID: 33408167. DOI: 10.1212/NXI.0000000000000940. http://www.ncbi.nlm.nih.gov/pubmed/33408167 +Pubmed +DOI
• Fico G, Anmella G, Gomez-Ramiro M, de Miquel C, Hidalgo-Mazzei D, Manchia M, Alda M, Gonzalez-Pinto A, Carvalho AF, Vieta E, Murru A. Duration of untreated illness and bipolar disorder: time for a new definition? Results from a cross-sectional study. J Affect Disord. 2021 Nov 1;294:513-520. doi: 10.1016/j.jad.2021.07.062. Epub 2021 Jul 22. PubMed PMID: 34330047. +Pubmed +DOI
• Fonseca E, Campos Blanco DM, Castro Vilanova MD, Garamendi Í, Gómez-Eguilaz M, Pérez Díaz H, Poza JJ, Querol-Pascual MR, Quiroga-Subirana P, Rodríguez-Osorio X, Zurita Santamaría J, Centeno M, Díaz de Cerio Julián L, Estévez-María JC, Martínez Agredano P, Mauri Llerda JÁ, Sala-Padró J, Falip M, Abraira L, Santamarina E, Seijo-Raposo I, Quintana M, Toledo M. Relationship between sleep quality and cognitive performance in patients with epilepsy. Epilepsy Behav. 2021 Sep;122:108127. doi: 10.1016/j.yebeh.2021.108127. Epub 2021 Jun 17. PubMed PMID: 34147020. +Pubmed +DOI
• Fonseca E, Campos Blanco DM, Castro Vilanova MD, Garamendi Í, Gómez-Eguilaz M, Pérez Díaz H, Poza JJ, Querol-Pascual MR, Quiroga-Subirana P, Rodríguez-Osorio X, Zurita Santamaría J, Centeno M, Díaz de Cerio Julián L, Estévez-María JC, Martínez Agredano P, Mauri Llerda JÁ, Sala-Padró J, Falip M, Abraira L, Santamarina E, Seijo-Raposo I, Quintana M, Toledo M. Relationship between sleep quality and cognitive performance in patients with epilepsy. Epilepsy Behav. 2021;122:108127. PMID: 34147020. DOI: 10.1016/j.yebeh.2021.108127. http://www.ncbi.nlm.nih.gov/pubmed/34147020 +Pubmed +DOI
• Fraguas D, Zarco J, Balanzá-Martínez V, Blázquez García JF, Borràs Murcia C, Cabrera A, Carretero J, Crespo A, Díaz-Marsá M, Gasul V, González MA, Grande I, Muela C, de Las Heras Liñero E, Mayoral F, Morales Cano G, Pagés-Lluyot JR, Romo J, Serrano Marín B, Lozano Sauceda A, Arango C. Humanization in mental health plans in Spain. Rev Psiquiatr Salud Ment (Engl Ed). 2021 Sep 4. pii: S1888-9891(21)00098-7. doi: 10.1016/j.rpsm.2021.08.003. [Epub ahead of print] English, Spanish. PubMed PMID: 34492375. +Pubmed +DOI
• Fraguas D, Zarco J, Balanzá-Martínez V, Blázquez García JF, Borràs Murcia C, Cabrera A, Carretero J, Crespo A, Díaz-Marsá M, Gasul V, González MA, Grande I, Muela C, de Las Heras Liñero E, Mayoral F, Morales Cano G, Pagés-Lluyot JR, Romo J, Serrano Marín B, Lozano Sauceda A, Arango C. Humanization in mental health plans in Spain. Rev Psiquiatr Salud Ment. 2021 Sep;(E-PUB) PMID: 34492375. DOI: 10.1016/j.rpsm.2021.08.003. http://www.ncbi.nlm.nih.gov/pubmed/34492375 +Pubmed +DOI
• Gómez-Ramiro M, Fico G, Anmella G, Vázquez M, Sagué-Vilavella M, Hidalgo-Mazzei D, Pacchiarotti I, Garriga M, Murru A, Parellada E, Vieta E. Changing trends in psychiatric emergency service admissions during the COVID-19 outbreak: Report from a worldwide epicentre. J Affect Disord. 2021 Mar 1;282:26-32. doi: 10.1016/j.jad.2020.12.057. Epub 2020 Dec 27. PubMed PMID: 33387743; PubMed Central PMCID: PMC7765763. +Pubmed +DOI
• Hernández-Rubio L, Asensio-Asensio M, Tortosa-Conesa D, Alfaro-Sáez A, García-Escrivá A, Díaz-Román M, Montoya J, Méndez-Miralles MA, Bertol-Alegre V, Castro-Vilanova MD, Galiano ML, Blanco-Cantó ME, López-González F. [Alzemon: a prospective follow-up study of eslicarbazepine acetate monotherapy in patients with newly diagnosed epilepsy]. Rev Neurol. 2021 Apr 16;72(8):263-268. doi: 10.33588/rn.7208.2020593. Spanish. PubMed PMID: 33851715. +Pubmed +DOI
• Hernández-Rubio L, Asensio-Asensio M, Tortosa-Conesa D, Alfaro-Sáez A, García-Escrivá A, Díaz-Román M, Montoya J, Méndez-Miralles MA, Bertol-Alegre V, Castro-Vilanova MD, Galiano ML, Blanco-Cantó ME, López-González F. [Alzemon: a prospective follow-up study of eslicarbazepine acetate monotherapy in patients with newly diagnosed epilepsy]. Rev Neurol. 2021 Apr;72(8):263–8. PMID: 33851715. DOI: 10.33588/rn.7208.2020593. http://www.ncbi.nlm.nih.gov/pubmed/33851715 +Pubmed +DOI
• Juan-García FJ, Ouviña-Arribas R. [Use of ultrasound in decision-making on painful shoulder]. Rehabilitacion (Madr). 2021 Oct-Dec;55(4):329-330. doi: 10.1016/j.rh.2021.01.004. Epub 2021 Mar 1. Spanish. PubMed PMID: 33663809. +Pubmed +DOI
• Madero S, Anmella G, Sagué-Vilavella M, Pons MT, Giménez A, Murru A, Gómez-Ramiro M, Gil-Badenes J, Rios J, Bioque M, Vieta E, Benabarre A. Evaluating maintenance electroconvulsive therapy in Bipolar Disorders: 3-year mirror-image study. J Affect Disord. 2022 Feb 1;298(Pt A):58-64. doi: 10.1016/j.jad.2021.10.052. Epub 2021 Oct 27. PubMed PMID: 34715196. +Pubmed +DOI
• Meca-Lallana JE, Maurino J, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, Prefasi D, Gómez-Ballesteros R, Ballesteros J. Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire. PLoS One. 2021 Jul 29;16(7):e0255317. doi: 10.1371/journal.pone.0255317. eCollection 2021. PubMed PMID: 34324586; PubMed Central PMCID: PMC8320986. +Pubmed +DOI
• Meca-Lallana JE, Maurino J, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, Prefasi D, Gómez-Ballesteros R, Ballesteros J. Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire. PLoS One. 2021;16(7):e0255317. PMID: 34324586. DOI: 10.1371/journal.pone.0255317. http://www.ncbi.nlm.nih.gov/pubmed/34324586 +Pubmed +DOI
• Meca-Lallana JE, Prefasi D, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, de Castro-Trapiello H, Canal N, Maurino J. Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder. Patient Prefer Adherence. 2021 Apr 12;15:713-719. doi: 10.2147/PPA.S305707. eCollection 2021. PubMed PMID: 33880015; PubMed Central PMCID: PMC8052114. +Pubmed +DOI
• Meca-Lallana JE, Prefasi D, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, de Castro-Trapiello H, Canal N, Maurino J. Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder. Patient Prefer Adherence. 2021;15:713–9. PMID: 33880015. DOI: 10.2147/PPA.S305707. http://www.ncbi.nlm.nih.gov/pubmed/33880015 +Pubmed +DOI
• Olivares JM, González-Pinto A, Páramo M, PROSIGO Study Group. Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study. Eur Psychiatry. 2021 Apr;64(1):e40. PMID: 33840396. DOI: 10.1192/j.eurpsy.2021.23. http://www.ncbi.nlm.nih.gov/pubmed/33840396 +Pubmed +DOI
• Olivares JM, González-Pinto A, Páramo M, PROSIGO Study Group. Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study. Eur Psychiatry. 2021 Apr;64(1):e40. PMID: 33840396. DOI: 10.1192/j.eurpsy.2021.23. http://www.ncbi.nlm.nih.gov/pubmed/33840396 +Pubmed +DOI
• Penedo MA, Rivera-Baltanás T, Pérez-Rodríguez D, Allen J, Borrajo A, Alonso-Crespo D, Fernández-Pereira C, Nieto-Araujo M, Ramos-García S, Barreiro-Villar C, Caruncho HJ, Olivares JM, Agís-Balboa RC. The role of dopamine receptors in lymphocytes and their changes in schizophrenia. Brain Behav Immun Health. 2021 Jan 7;12:100199. doi: 10.1016/j.bbih.2021.100199. eCollection 2021 Mar. Review. PubMed PMID: 34589732; PubMed Central PMCID: PMC8474470. +Pubmed +DOI
• Penedo MA, Rivera-Baltanás T, Pérez-Rodríguez D, Allen J, Borrajo A, Alonso-Crespo D, Fernández-Pereira C, Nieto-Araujo M, Ramos-García S, Barreiro-Villar C, Caruncho HJ, Olivares JM, Agís-Balboa RC. The role of dopamine receptors in lymphocytes and their changes in schizophrenia. Brain, Behav Immun – Heal. 2021 Mar;12:100199. PMID: 34589732. DOI: 10.1016/j.bbih.2021.100199. http://www.ncbi.nlm.nih.gov/pubmed/34589732 +Pubmed +DOI
• Pérez-Rodríguez D, López-Fernández H, Agís-Balboa RC. Application of miRNA-seq in neuropsychiatry: A methodological perspective. Comput Biol Med. 2021 Jun;135:104603. PMID: 34216893. DOI: 10.1016/j.compbiomed.2021.104603. http://www.ncbi.nlm.nih.gov/pubmed/34216893 +Pubmed +DOI
• Pérez-Rodríguez D, López-Fernández H, Agís-Balboa RC. Application of miRNA-seq in neuropsychiatry: A methodological perspective. Comput Biol Med. 2021 Jun;135:104603. PMID: 34216893. DOI: 10.1016/j.compbiomed.2021.104603. http://www.ncbi.nlm.nih.gov/pubmed/34216893 +Pubmed +DOI
• Rodrigues-Amorim D, Iglesias-Martínez-Almeida M, Rivera-Baltanás T, Fernández-Palleiro P, Freiría-Martínez L, Rodríguez-Jamardo C, Comís-Tuche M, Vallejo-Curto MDC, Álvarez-Ariza M, López-García M, de Las Heras E, García-Caballero A, Olivares JM, Spuch C. The Role of the Second Extracellular Loop of Norepinephrine Transporter, Neurotrophin-3 and Tropomyosin Receptor Kinase C in T Cells: A Peripheral Biomarker in the Etiology of Schizophrenia. Int J Mol Sci. 2021 Aug 7;22(16). pii: 8499. doi: 10.3390/ijms22168499. PubMed PMID: 34445205; PubMed Central PMCID: PMC8395201. +Pubmed +DOI
• Rodrigues-Amorim D, Iglesias-Martínez-Almeida M, Rivera-Baltanás T, Fernández-Palleiro P, Freiría-Martínez L, Rodríguez-Jamardo C, Comís-Tuche M, Vallejo-Curto MDC, Álvarez-Ariza M, López-García M, de Las Heras E, García-Caballero A, Olivares JM, Spuch C. The Role of the Second Extracellular Loop of Norepinephrine Transporter, Neurotrophin-3 and Tropomyosin Receptor Kinase C in T Cells: A Peripheral Biomarker in the Etiology of Schizophrenia. Int J Mol Sci. 2021 Aug;22(16):8499. PMID: 34445205. DOI: 10.3390/ijms22168499. http://www.ncbi.nlm.nih.gov/pubmed/34445205 +Pubmed +DOI
• Rodrigues-Amorim D, Rivera-Baltanás T, Fernández-Palleiro P, Iglesias-Martínez-Almeida M, Freiría-Martínez L, Jarmardo-Rodriguez C, Del Carmen Vallejo-Curto M, Álvarez-Ariza M, López-García M, de Las Heras E, García-Caballero A, Olivares JM, Spuch C. Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target. Cell Mol Neurobiol. 2021 Mar;(E-PUB) PMID: 33712885. DOI: 10.1007/s10571-021-01073-8. http://www.ncbi.nlm.nih.gov/pubmed/33712885 +Pubmed +DOI
• Rodrigues-Amorim D, Rivera-Baltanás T, Fernández-Palleiro P, Iglesias-Martínez-Almeida M, Freiría-Martínez L, Jarmardo-Rodriguez C, Del Carmen Vallejo-Curto M, Álvarez-Ariza M, López-García M, de Las Heras E, García-Caballero A, Olivares JM, Spuch C. Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target. Cell Mol Neurobiol. 2021 Mar;(E-PUB) PMID: 33712885. DOI: 10.1007/s10571-021-01073-8. http://www.ncbi.nlm.nih.gov/pubmed/33712885 +Pubmed +DOI
• Rodríguez de Antonio LA, García Castañón I, Aguilar-Amat Prior MJ, Puertas I, González Suárez I, Oreja Guevara C. Non-inflammatory causes of emergency consultation in patients with multiple sclerosis. Neurologia (Engl Ed). 2021 Jul-Aug;36(6):403-411. doi: 10.1016/j.nrleng.2018.02.005. Epub 2020 Mar 31. PubMed PMID: 34238522. +Pubmed +DOI
• Rodríguez de Antonio LA, García Castañón I, Aguilar-Amat Prior MJ, Puertas I, González Suárez I, Oreja Guevara C. Non-inflammatory causes of emergency consultation in patients with multiple sclerosis. Neurologia. 2021;36(6):403–11. PMID: 34238522. DOI: 10.1016/j.nrleng.2018.02.005. http://www.ncbi.nlm.nih.gov/pubmed/34238522 +Pubmed +DOI
• Rodríguez de Antonio LA, González-Suárez I, Fernández-Barriuso I, Rabasa Pérez M. Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review. Mult Scler Relat Disord. 2021 Apr;49:102783. PMID: 33513521. DOI: 10.1016/j.msard.2021.102783. http://www.ncbi.nlm.nih.gov/pubmed/33513521 +Pubmed +DOI
• Rodríguez de Antonio LA, González-Suárez I, Fernández-Barriuso I, Rabasa Pérez M. Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review. Mult Scler Relat Disord. 2021 Apr;49:102783. PMID: 33513521. DOI: 10.1016/j.msard.2021.102783. http://www.ncbi.nlm.nih.gov/pubmed/33513521 +Pubmed +DOI
• Rodríguez-Osorio X, Lema-Facal T, Rubio-Nazábal E, Castro-Vilanova MD, Pato-Pato A, Abella-Corral J, Corredera E, López-Ferreiro A, Puy-Núñez A, López-González FJ. Perampanel effectiveness and safety as early add-on treatment for focal-onset seizures: PEREAGAL study. Epilepsy Res. 2021 May;172:106570. doi: 10.1016/j.eplepsyres.2021.106570. Epub 2021 Feb 4. PubMed PMID: 33621770. +Pubmed +DOI
• Rodríguez-Osorio X, Lema-Facal T, Rubio-Nazábal E, Castro-Vilanova MD, Pato-Pato A, Abella-Corral J, Corredera E, López-Ferreiro A, Puy-Núñez A, López-González FJ. Perampanel effectiveness and safety as early add-on treatment for focal-onset seizures: PEREAGAL study. Epilepsy Res. 2021;172:106570. PMID: 33621770. DOI: 10.1016/j.eplepsyres.2021.106570. http://www.ncbi.nlm.nih.gov/pubmed/33621770 +Pubmed +DOI
• Such P, Olivares JM, Arias L, Troels Berg M, Madera J. Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate. Neuropsychiatr Dis Treat. 2021 Jun 10;17:1881-1892. doi: 10.2147/NDT.S303292. eCollection 2021. PubMed PMID: 34140772; PubMed Central PMCID: PMC8203189. +Pubmed +DOI
• Such P, Olivares JM, Arias L, Troels Berg M, Madera J. Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate. Neuropsychiatr Dis Treat. 2021;17:1881–92. PMID: 34140772. DOI: 10.2147/NDT.S303292. http://www.ncbi.nlm.nih.gov/pubmed/34140772 +Pubmed +DOI
• Vaamonde-Lorenzo L, Juan-García FJ. [Rehabilitation physician involvement in teaching biomedical engineering]. Rehabilitacion (Madr). 2021 Oct-Dec;55(4):330-331. doi: 10.1016/j.rh.2021.03.002. Epub 2021 Apr 9. Spanish. PubMed PMID: 33846020. +Pubmed +DOI
• Vallejo-Curto MDC, Rodrigues-Amorim D, Jardón-Golmar L, Blanco-Formoso M, Rivera-Baltanás T, Rodriguez-Jamardo C, Fernández-Palleiro P, Álvarez-Ariza M, López-García M, García-Caballero A, de Las Heras E, Olivares JM, Spuch C. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study. Rev Psiquiatr Salud Ment. 2020 Nov;14(3):125–38. PMID: 33264672. DOI: 10.1016/j.rpsm.2020.11.001. http://www.ncbi.nlm.nih.gov/pubmed/33264672 +Pubmed +DOI
• Vallejo-Curto MDC, Rodrigues-Amorim D, Jardón-Golmar L, Blanco-Formoso M, Rivera-Baltanás T, Rodriguez-Jamardo C, Fernández-Palleiro P, Álvarez-Ariza M, López-García M, García-Caballero A, de Las Heras E, Olivares JM, Spuch C. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study. Rev Psiquiatr Salud Ment. 2021 Nov;14(3):125–38. PMID: 34384726. DOI: 10.1016/j.rpsmen.2021.07.002. http://www.ncbi.nlm.nih.gov/pubmed/34384726 +Pubmed +DOI

Capítulos de libro

• Carlos Spuch. Capítulo 8. Página 181-248. Microbiotica.Título : EL IMPACTO DE LA NUEVA MEDICINA EN EL SISTEMA SANITARIO. ISBN OBRA COMPLETA: 978-84-09-27161-0 ISBN VOLUMEN I: 978-84-09-27240-2. Depósito legal: M-1731-2021. ISBN VOLUMEN II: 978-84-09-27239-6 Depósito legal: M-2831-2021

Guías de Práctica

• Humanización en Salud Mental. ISBN: 978-84-17372-95-8. Depósito Legal: M-1958-2020

Artigos Científicos

• Bartolome F, Krzyzanowska A, de la Cueva M, Pascual C, Antequera D, Spuch C, Villarejo-Galende A, Rabano A, Fortea J, Alcolea D, Lleo A, Ferrer I, Hardy J, Abramov AY, Carro E. Annexin A5 prevents amyloid-?-induced toxicity in choroid plexus: implication for Alzheimer´s disease. Sci Rep. 2020;10(1):9391. PMID: 32523019. DOI: 10.1038/s41598-020-66177-5. http://www.ncbi.nlm.nih.gov/pubmed/32523019 +Pubmed +DOI
• Fernández-Palleiro P, Rivera-Baltanás T, Rodrigues-Amorim D, Fernández-Gil S, Del Carmen Vallejo-Curto M, Álvarez-Ariza M, López M, Rodriguez-Jamardo C, Luis Benavente J, de Las Heras E, Manuel Olivares J, Spuch C. Brainwaves Oscillations as a Potential Biomarker for Major Depression Disorder Risk. Clin EEG Neurosci. 2020 Jan;51(1):3–9. PMID: 31537100. DOI: 10.1177/1550059419876807. http://www.ncbi.nlm.nih.gov/pubmed/31537100 +Pubmed +DOI
• Manzano-Palomo S, Agüera-Ortiz LF, García-Caballero A, Martínez-Raga J, Ojea-Ortega T, Sánchez-Valle R, Antón-Jiménez M, Monge-Argilés JA, Ramos-García I. Use of Antipsychotics in Patients with Behavioral and Psychological Symptoms of Dementia: Results of a Spanish Delphi Consensus. Dement Geriatr Cogn Disord. 2020;49(6):573–82. PMID: 33176326. DOI: 10.1159/000510866. http://www.ncbi.nlm.nih.gov/pubmed/33176326 +Pubmed +DOI
• Martínez RÁ, Rodríguez RMT, Ariza MÁ, Spuch C, Olivares JM. Mania as Debut of Cushing´s Syndrome. Case Rep Psychiatry. 2020 Mar;2020:9127632. PMID: 32190397. DOI: 10.1155/2020/9127632. http://www.ncbi.nlm.nih.gov/pubmed/32190397 +Pubmed +DOI
• Mercadé Cerdá JM, López Gonzalez FJ, Serrano Castro P, Castro Vilanova MD, Campos Blanco DM, Querol Pascual MR; en representación del Grupo de Estudio de Epilepsia de la SEN. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations. Neurologia (Engl Ed). 2020 Mar;35(2):115-125. doi: 10.1016/j.nrl.2018.01.011. Epub 2018 Mar 9. English, Spanish. PubMed PMID: 29530436. +Pubmed +DOI
• Pinón-Blanco A, Vergara-Moragues E, Fernández-Martínez R, Gutiérrez-Martínez O, Alvarez-Counago M, Martínez-Reglero C, Rivera-Baltanás T, Otero-Lamas F, Olivares-Diez J, Spuch-Calvar C. Effectiveness of the “Trisquel” board game intervention program for patients with schizophrenia spectrum disorders. Actas Esp Psiquiatr. 2020;48(5):209–19. PMID: 33210279. http://www.ncbi.nlm.nih.gov/pubmed/33210279 +Pubmed
• Rodrigues-Amorim D, Olivares JM, Spuch C, Rivera-Baltanás T. A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine. Front psychiatry. 2020;11:554899. PMID: 33192668. DOI: 10.3389/fpsyt.2020.554899. http://www.ncbi.nlm.nih.gov/pubmed/33192668 +Pubmed +DOI
• Rodrigues-Amorim D, Rivera-Baltanás T, Del Carmen Vallejo-Curto M, Rodriguez-Jamardo C, de Las Heras E, Barreiro-Villar C, Blanco-Formoso M, Fernández-Palleiro P, Álvarez-Ariza M, López M, García-Caballero A, Olivares JM, Spuch C. Plasma ?-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia. Sci Rep. 2020;10(1):14271. PMID: 32868793. DOI: 10.1038/s41598-020-71060-4. http://www.ncbi.nlm.nih.gov/pubmed/32868793 +Pubmed +DOI
• Spuch C, López-García M, Rivera-Baltanás T, Rodrígues-Amorím D, Olivares JM. Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report. Front Pharmacol. 2020 Aug;11:557629. PMID: 32973537. DOI: 10.3389/fphar.2020.557629. http://www.ncbi.nlm.nih.gov/pubmed/32973537 +Pubmed +DOI
• Tejada Meza H, Lambea Gil Á, Sancho Saldaña A, Martínez-Zabaleta M, Garmendia Lopetegui E, López-Cancio Martínez E, Castañón Apilánez M, Herrera Isasi M, Marta Enguita J, Gómez-Vicente B, Arenillas JF, Arenaza Basterrechea N, Timiraos Fernández JJ, Sánchez Herrero J, Maciñeiras Montero JL, Castellanos Rodrigo M, Fernández-Coud D, Casado Menéndez I, Temprano Fernández MT, Freijo M, Luna A, Palacio Portilla EJ, Jiménez López Y, Rodríguez-Castro E, Rodríguez-Yáñez M, Tejada García J, Beltrán Rodríguez I, Julián-Villaverde F, Moreno García MP, Trejo Gabriel-Galán JM, Echavarría Iñiguez A, Pérez Lázaro C, Navarro Pérez MP, Marta Moreno J, NORDICTUS Investigators. Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain. Eur J Neurol. 2020;27(12):2491–8. PMID: 32761981. DOI: 10.1111/ene.14467. http://www.ncbi.nlm.nih.gov/pubmed/32761981 +Pubmed +DOI
• Toledano Delgado R, García-Morales I, Parejo-Carbonell B, Jiménez-Huete A, Herrera-Ramirez D, González-Hernández A, Ayuga Loro F, Santamarina E, Toledo M, Ojeda J, Poza JJ, Molins A, Giner P, Estévez María JC, Castro-Vilanova MD, Zurita J, Saiz-Diaz RA, Gómez-Ibañez A, Rodriguez-Uranga J, Gil-Nagel A, Campos D, Sánchez-Larsen Á, Aguilar-Amat Prior MJ, Mauri Llerda JA, Huertas González N, García-Barragán N. Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry. Epilepsia. 2020;61(6):1109–19. PMID: 32511754. DOI: 10.1111/epi.16548. http://www.ncbi.nlm.nih.gov/pubmed/32511754 +Pubmed +DOI

Capítulos de libro

• Álvarez Martínez R, Tomé Rodríguez RM, Álvarez Ariza M, Spuch C, Olivares JM. Mania as Debut of Cushing´s Syndrome. In: Borregón Rivilla M (ed.). Case Reports For Medical Practitioners. Hyderabad, India: Vide Leaf; 2020. p. 1–7. ISBN: 978-93-90014-16-3. https://videleaf.com/mania-as-debut-of-cushings-syndrome-a-case-report/ Enlace
• Spuch C, López-García M, Rivera-Baltanás T, Rodrígues-Amorím D, Olivares JM. Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report. In: Borregón Rivilla M (ed.). Case Reports For Medical Practitioners. Hyderabad, India: Vide Leaf; 2020. p. 1–18. ISBN: 978-93-90014-16-3. https://videleaf.com/does-lithium-deserve-a-place-in-the-treatment-against-covid-19-a-preliminary-observational-study-in-six-patients-case-report/ Enlace

Artigos Científicos

• Arango C, Baeza I, Bernardo M, Cañas F, de Dios C, Díaz-Marsá M, García-Portilla MP, Gutiérrez-Rojas L, Olivares JM, Rico-Villademoros F, Rodríguez-Jiménez R, Sánchez-Morla EM, Segarra R, Crespo-Facorro B. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain. Rev Psiquiatr Salud Ment. 2019 Jun;12(2):92–105. PMID: 29954707. DOI: 10.1016/j.rpsm.2018.03.006. http://www.ncbi.nlm.nih.gov/pubmed/29954707 +Pubmed +DOI
• Caruncho HJ, Kalynchuk LE, Loza MI, Olivares JM. Editorial: Novel Approaches to the Neuropharmacology of Mood Disorders. Front Pharmacol. 2019;10(MAY):589. PMID: 31156442. DOI: 10.3389/fphar.2019.00589. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533613/pdf/fphar-10-00589.pdf +Pubmed +DOI
• Caruncho HJ, Rivera-Baltanas T, Romay-Tallon R, Kalynchuk LE, Olivares JM. Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder. Front Pharmacol. 2019;10(March):190. PMID: 30930773. DOI: 10.3389/fphar.2019.00190. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423346/pdf/fphar-10-00190.pdf +Pubmed +DOI
• Dieguez-Varela C, Lion-Vazquez S, Fraga-Bau A, Rodriguez-Acevedo B, Rodriguez-Sanchez L, Collazo-Dieguez M, Pereira-Martinez MN, Salgado-Barreira A, Alvarez-Rodriguez E, Vicente-Alba P, Munoz D, Fernandez JM, Ribeiro SJ, Midaglia L. [Intermittent theta-burst transcranial magnetic stimulation for the treatment of spasticity in patients with recurring multiple sclerosis: the results of a double-blind randomised clinical trial]. Rev Neurol. 2019 Jul;69(2):45–52. PMID: 31287147. DOI: 10.33588/rn.6902.2018275. http://www.ncbi.nlm.nih.gov/pubmed/31287147 +Pubmed +DOI
• Gallastegui C, Fernández-Vega H, Piñeiro G, Rey-Gómez-Serranillos I, Olivares JM, De Las Heras-Liñero E. Evaluación de la adherencia al tratamiento con antipsicóticos inyectables de liberación prolongada dentro de un programa de seguimiento farmacoterapéutico. Farm Hosp. 2019;43(6):177–81. PMID: 31705640. DOI: 10.7399/fh.11188. http://www.aulamedica.es/fh/pdf/11188.pdf +Pubmed +DOI
• Lado-Codesido M, Méndez Pérez C, Mateos R, Olivares JM, García Caballero A. Improving emotion recognition in schizophrenia with “VOICES”: An on-line prosodic self-training. PLoS One. 2019;14(1):e0210816. PMID: 30682067. DOI: 10.1371/journal.pone.0210816. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347191/pdf/pone.0210816.pdf +Pubmed +DOI
• Piñon Blanco A, Lage López M, Carrera Machado I, Vázquez González M, Cerqueiro Costa X, Bobadilla Pérez V, Spuch Calvar C, Otero Lamas F. Perfil neuropsicológico y sintomatología psicopatológica de pacientes con trastornos relacionados con sustancias a tratamiento en una unidad de día. Heal Addict y Drog. 2019 Feb;19(1):70–9. DOI: 10.21134/haaj.v19i1.412. https://ojsnuevo.haaj.org/index.php/haaj/article/view/412 +DOI
• Piñón-Blanco A, Carballido E, Vázquez E, Fernandes S, Gutiérrez O, Spuch C. Rendimiento neuropsicológico de niños y niñas con Trastorno por Déficit de Atención e Hiperactividad (TDAH). Cuad Neuropsicol / Panam J Neuropsychol. 2019 Jan;13(1):116–32. DOI: 10.7714/CNPS/13.1.206. https://dialnet.unirioja.es/servlet/articulo?codigo=6934930# +DOI
• Rodrigues-Amorim D, Rivera-Baltanás T, Vallejo-Curto M del C, Rodriguez-Jamardo C, de Las Heras E, Barreiro-Villar C, Blanco-Formoso M, Fernández-Palleiro P, Álvarez-Ariza M, López M, García-Caballero A, Olivares JM, Spuch C. Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways. Front psychiatry. 2019;10(November):885. PMID: 31849731. DOI: 10.3389/fpsyt.2019.00885. http://www.ncbi.nlm.nih.gov/pubmed/31849731 +Pubmed +DOI
• Salagre E, Arango C, Artigas F, Ayuso-Mateos JL, Bernardo M, Castro-Fornieles J, Bobes J, Desco M, Fañanás L, González-Pinto A, Haro JM, Leza JC, Mckenna PJ, Meana JJ, Menchón JM, Micó JA, Palomo T, Pazos Á, Pérez V, Saiz-Ruiz J, Sanjuán J, Tabarés-Seisdedos R, Crespo-Facorro B, Casas M, Vilella E, Palao D, Olivares JM, Rodriguez-Jimenez R, Vieta E. CIBERSAM: Ten years of collaborative translational research in mental disorders. Rev Psiquiatr Salud Ment. 2019 Jan;12(1):1–8. PMID: 30416047. DOI: 10.1016/j.rpsm.2018.10.001. http://www.ncbi.nlm.nih.gov/pubmed/30416047 +Pubmed +DOI
• Sánchez-Reales S, Caballero-Peláez C, Prado-Abril J, Inchausti F, Lado-Codesido M, García-Caballero A, Lahera G. Spanish validation of the “Reading the Mind in the Voice” task: A study of complex emotion recognition in adults with autism spectrum conditions. Res Autism Spectr Disord. 2019 Nov;67:101421. DOI: 10.1016/j.rasd.2019.101421. http://doi.org/10.1016/j.rasd.2019.101421 +DOI
• Toledo M, Mazuela G, Mauri JA, Rodriguez-Osorio X, Gómez-Eguilaz M, Castro-Vilanova D, Rodriguez-Uranga J, Santamarina E. Levels of anger in epilepsy patients treated with eslicarbazepine acetate. Acta Neurol Scand. 2019 Jul;140(1):48-55. doi: 10.1111/ane.13099. Epub 2019 May 9. PubMed PMID: 30953593. +Pubmed +DOI
• Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F; EURAP Study Group. Declining malformation rates with changed antiepileptic drug prescribing: An observational study. Neurology. 2019 Aug 27;93(9):e831-e840. doi: 10.1212/WNL.0000000000008001. Epub 2019 Aug 7. PubMed PMID: 31391249. +Pubmed +DOI
• Villanueva V, Bermejo P, Montoya J, Massot-Tarrús A, Galiano ML, Toledo M, Rodriguez-Uranga JJ, Bertol V, Mauri JÁ, Poza JJ, Bonet M, Castro-Vilanova MD, Ruiz-Giménez J, López-González FJ, Rodríguez-Osorio X, Tortosa-Conesa D, Ojeda J, Giner P, Garcés M, Alvarez BM, Quiroga-Subirana P, Esteve P, Baiges JJ, Hampel K. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy. Epilepsy Behav. 2019;97:51–9. PMID: 31181429. DOI: 10.1016/j.yebeh.2019.05.003. http://www.ncbi.nlm.nih.gov/pubmed/31181429 +Pubmed +DOI
• Villanueva V, López-González FJ, Mauri JA, Rodriguez-Uranga J, Olivé-Gadea M, Montoya J, Ruiz-Giménez J, Zurita J; BRIVA-LIFE study group. BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice. Acta Neurol Scand. 2019 Apr;139(4):360-368. doi: 10.1111/ane.13059. Epub 2018 Dec 27. PubMed PMID: 30506559. +Pubmed +DOI

Artigos Científicos

• Alcaraz S, González-Saiz F, Trujols J, Vergara-Moragues E, Siñol N, Pérez de Los Cobos J, Buprenorphine Naloxone Survey Group (Manuel Conde). A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers. Drug Alcohol Depend. 2018;187:278–84. PMID: 29702336. DOI: 10.1016/j.drugalcdep.2018.02.020. http://www.ncbi.nlm.nih.gov/pubmed/29702336 +Pubmed +DOI
• Fernández M, Lago L, Alonso MG, Guede A, Benavente JL, Olivares JM. Serotonin syndrome versus neuroleptic malignant syndrome: a case report. Actas españolas Psiquiatr. 2018 Mar;46(2):68–74. PMID: 29616715. http://www.ncbi.nlm.nih.gov/pubmed/29616715 +Pubmed
• Formigo J, Juan-Garcia FJ. Utilidad de la punción-aspiración con aguja fina ecoguiada, tras la aplicación de ondas de choque extracorpóreas en la tendinitis del manguito de los rotadores. Espac Dolor. 2018;1(1):23–5.
• García-Caballero TM, Lojo J, Menéndez C, Fernández-Álvarez R, Mateos R, Garcia-Caballero A. Polimedication: applicability of a computer tool to reduce polypharmacy in nursing homes. Int psychogeriatrics. 2018 Jul;30(7):1001–8. PMID: 29747709. DOI: 10.1017/S1041610217002411. http://www.ncbi.nlm.nih.gov/pubmed/29747709 +Pubmed +DOI
• González-Saiz F, Lozano Rojas O, Trujols J, Alcaraz S, Siñol N, Pérez de Los Cobos J, Buprenorphine Naloxone Survey Group (Manuel Conde). Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment. Drug Alcohol Depend. 2018;183:127–33. PMID: 29247974. DOI: 10.1016/j.drugalcdep.2017.10.035. http://www.ncbi.nlm.nih.gov/pubmed/29247974 +Pubmed +DOI
• Maroño Souto Y, Vázquez Campo M, Díaz Llenderrozas F, Rodríguez Álvarez M, Mateos R, García Caballero A. Randomized Clinical Trial with e-MotionalTraining® 1.0 for Social Cognition Rehabilitation in Schizophrenia. Front psychiatry. 2018;9(FEB):40. PMID: 29535646. DOI: 10.3389/fpsyt.2018.00040. http://www.ncbi.nlm.nih.gov/pubmed/29535646 +Pubmed +DOI
• Muñoz-Lopetegi A, López-González FJ, Rodríguez-Osorio X, Pato Pato A, Bellas Lamas P, Abella-Corral J, Castro Vilanova MD, Garea MJ, Gil López JA, Ruiz-Martínez J, Poza JJ. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting. Epilepsy Res. 2018 Sep;145:51-54. doi: 10.1016/j.eplepsyres.2018.05.011. Epub 2018 May 31. PubMed PMID: 29890341. +Pubmed +DOI
• Piñón Blanco A, Vergara Moragues E, Torres Rincón T, Gutiérrez Martínez O, Conde Amado M, Vázquez Justo E, Otero Lamas F. Diferencias entre hombres y mujeres en los procesos de toma de decisiones en pacientes con trastornos relacionados con sustancias. Rev Latinoam Psicol. 2018 Dec;50(1):160–9. DOI: 10.14349/rlp.2018.v50.n3.3. http://dx.doi.org/10.14349/rlp.2018.v50.n3.3 +DOI
• Piñón-Blanco A, Álvarez MC, Torres-Rincón TM, Vázquez P, Otero F. Neuropsychological profile of patients diagnosed with schizophrenia spectrum disorder. Rev Discapacidad, Clínica y Neurociencias. 2018;5(1):1–04. https://dialnet.unirioja.es/servlet/articulo?codigo=6312752 Enlace
• Rodrigues-Amorim D, Rivera-Baltanás T, Bessa J, Sousa N, Vallejo-Curto M de C, Rodríguez-Jamardo C, de Las Heras ME, Díaz R, Agís-Balboa RC, Olivares JM, Spuch C. The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis. J Psychiatr Res. 2018;106:43–53. PMID: 30269004. DOI: 10.1016/j.jpsychires.2018.09.007. http://www.ncbi.nlm.nih.gov/pubmed/30269004 +Pubmed +DOI
• Rodrigues-Amorim D, Rivera-Baltanás T, Regueiro B, Spuch C, de Las Heras ME, Vázquez-Noguerol Méndez R, Nieto-Araujo M, Barreiro-Villar C, Olivares JM, Agís-Balboa RC. The role of the gut microbiota in schizophrenia: Current and future perspectives. World J Biol Psychiatry. 2018 Feb;19(8):571–85. PMID: 29383983. DOI: 10.1080/15622975.2018.1433878. http://www.ncbi.nlm.nih.gov/pubmed/29383983 +Pubmed +DOI
• Rodrigues-Amorim D, Rivera-Baltanás T, Spuch C, Caruncho HJ, González-Fernandez Á, Olivares JM, Agís-Balboa RC. Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship. Schizophr Res. 2018 Nov;197:19–33. PMID: 29239785. DOI: 10.1016/j.schres.2017.11.023. http://www.ncbi.nlm.nih.gov/pubmed/29239785 +Pubmed +DOI
• Rodríguez de Antonio LA, García Castañón I, Aguilar-Amat Prior MJ, Puertas I, González Suárez I, Oreja Guevara C. Non-inflammatory causes of emergency consultation in patients with multiple sclerosis. Neurologia. 2018 May;36(6):403–11. PMID: 29843902. DOI: 10.1016/j.nrl.2018.02.006. http://www.ncbi.nlm.nih.gov/pubmed/29843902 +Pubmed +DOI
• Romay-Tallon R, Kulhawy E, Brymer KJ, Allen J, Rivera-Baltanas T, Olivares JM, Kalynchuk LE, Caruncho HJ. Changes in Membrane Protein Clustering in Peripheral Lymphocytes in an Animal Model of Depression Parallel Those Observed in Naïve Depression Patients: Implications for the Development of Novel Biomarkers of Depression. Front Pharmacol. 2018;9:1149. PMID: 30374301. DOI: 10.3389/fphar.2018.01149. http://www.ncbi.nlm.nih.gov/pubmed/30374301 +Pubmed +DOI
• Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F; EURAP Study Group. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018 Jun;17(6):530-538. doi: 10.1016/S1474-4422(18)30107-8. Epub 2018 Apr 18. PubMed PMID: 29680205. +Pubmed +DOI
• Torres-Rincón TM, Pinion-Blanco A, Vázquez-Justo, Otero-Lamas. Neuropsychological alterations in borderline personality disorder: purpose of a case. J Psychol Clin Psychiatry. 2018 Nov;9(6):683–7. DOI: 10.15406/jpcpy.2018.09.00611. https://medcraveonline.com/JPCPY/JPCPY-09-00611 +DOI
• Vicente-Alba P, Moreno-Carretero MJ, San Millan-Tejado B, Outomuro-Perez JM. [Behavioural variant of frontotemporal dementia as the presenting symptom of corticobasal degeneration]. Rev Neurol. 2018 Dec;67(11):436–40. PMID: 30484276. http://www.ncbi.nlm.nih.gov/pubmed/30484276 +Pubmed
• Zapata-Wainberg G, Quintas S, Ximénez-Carrillo Rico Á, Masjuán Vallejo J, Cardona P, Castellanos Rodrigo M, Benavente Fernández L, García Pastor A, Egido J, Maciñeiras J, Serena J, Freijo Guerrero M del M, Moniche F, Vivancos J. Epidemiology of Intracranial Hemorrhage Associated with Oral Anticoagulants in Spain: Trends in Anticoagulation Complications Registry – The TAC 2 Study. Interv Neurol. 2018 Apr;7(5):284–95. PMID: 29765398. DOI: 10.1159/000487518. http://www.ncbi.nlm.nih.gov/pubmed/29765398 +Pubmed +DOI

Capítulos de libro

• Formigo-Couceiro J, Juan-García FJ, Barrio-Alonso M. Técnicas intervencionistas en el paciente con secuelas neurológicas: bloqueos de nervios periféricos en la espasticidad. Notas de Neurorrehabilitación. A Coruña: Editorial Seteis Comunicación Creatividade SL; 2018. p. 77–82. DL: C-1929-2018. ISBN: 978-84-09-06075-7.
• Formigo-Couceiro J, Juan-García FJ. Ecografía en Rehabilitación intervencionista. Cartera de Servicios. In: Formigo-Couceiro J, Juan-García FJ (eds.). Técnicas Básicas de Rehabilitación Intervencionista Ecoguiadas SOGARMEF. Enfoque Editorial S.C; 2018. p. 7–12. DL: M-31006-2018. ISBN: 978-84-16813-90-2. https://www.sogarmef.org/project/libro-tecnicas-basicas-de-rehabilitacion-intervencionista-ecoguiadas/ Enlace
• Formigo-Couceiro J, Juan-García FJ. Ecografía en Rehabilitación intervencionista. Cartera de Servicios. In: Formigo-Couceiro J, Juan-García FJ (eds.). Técnicas Básicas de Rehabilitación Intervencionista Ecoguiadas SOGARMEF. Enfoque Editorial S.C; 2018. p. 7–12. DL: M-31006-2018. ISBN: 978-84-16813-90-2. https://www.sogarmef.org/project/libro-tecnicas-basicas-de-rehabilitacion-intervencionista-ecoguiadas/ Enlace
• Formigo-Couceiro J, Juan-García FJ. Ecografía en Rehabilitación intervencionista. Cartera de Servicios. In: Formigo-Couceiro J, Juan-García FJ (eds.). Técnicas Básicas de Rehabilitación Intervencionista Ecoguiadas SOGARMEF. Enfoque Editorial S.C; 2018. p. 7–12. DL: M-31006-2018. ISBN: 978-84-16813-90-2. https://www.sogarmef.org/project/libro-tecnicas-basicas-de-rehabilitacion-intervencionista-ecoguiadas/ Enlace
• Grupo de trabajo del proyecto Biblioterapia Lecturas Saludables (María Álvarez Ariza; Elena de las Heras). Biblioterapia. Lecturas saludables. Consellería de Sanidade-Servicio Galego de Saúde, Axencia Galega para a Xestión do Coñecemento en Saúde (ACIS), Unidad de Asesoramiento científico-técnico. Avalia-t (eds.). Santiago de Compostela: Xunta de Galicia; 2018. DL: C 92-2019. https://bibliosaude.sergas.gal/DXerais/928/BIBLIOTERAPIA_lecturas saludables_ES.pdf Enlace
• Grupo de trabajo del proyecto Biblioterapia Lecturas Saludables (María Álvarez Ariza; Elena de las Heras). Biblioterapia. Lecturas saludables. Guía de libros recomendados. Consellería de Sanidade-Servicio Galego de Saude; Agencia Gallega para la Gestión del Conocimiento en Salud (ACIS); Unidad de Asesoramiento científico-técnico. Avalia-t (ed.). Santiago de Compostela: Xunta de Galicia; 2018. DL: C 93-2019. https://bibliosaude.sergas.gal/DXerais/928/GUÍA LIBROS RECOMENDADOS_ES.pdf Enlace
• Juan-García FJ, editor. Notas de Neurorrehabilitación. A Coruña: Editorial Seteis Comunicación Creatividade SL; 2018. DL: C-1929-2018. ISBN: 978-84-09-06075-7.
• Juan-Garcia FJ. Cuidados y evaluaciones periódicas en pacientes con lesión medular tras el alta de la fase aguda. Notas de Neurorrehabilitación. A Coruña: Editorial Seteis Comunicación Creatividade SL; 2018. p. 44–54. DL: C-1929-2018. ISBN: 978-84-09-06075-7.
• Juan-García FJ. Espasticidad en la Esclerosis Múltiple. Notas de Neurorrehabilitación. A Coruña: Editorial Seteis Comunicación Creatividade SL; 2018. p. 64–72. DL: C-1929-2018. ISBN: 978-84-09-06075-7.
• Reboiro-Jato M, López-Fernández H, Laza-Fidalgo R, Pavón-Rial MR, Rojas-Rodríguez F, Vieira-Vázquez A, Rivera-Baltanás T, Spuch-Calvar C, Varela-Pomar A, Otero-Lamas F, Piñón-Blanco A. MultiTasking Cubes: unha ferramenta para a rehabilitacion cognitiva. In: De-Blas-Varela E, Rodríguez-Vázquez V, Vila-Sobrino XA, Álvarez-González S (eds.). Proxectos INOU 2017 Investigación aplicada na provincia de Ourense. Universidade de Vigo; 2018. p. 63–77. DL: VG 665-2018. ISBN: 978-84-8158-800-2. https://dialnet.unirioja.es/servlet/articulo?codigo=6691641 Enlace

Guías de Práctica

• Alvarez-Ariza M, Alvarez Garcia C, Atienza-Merino G, Basanta Matos R, Goicoechea-Castaño A, De-las-Heras-Liñero E, Mazaira Castro J, Montiel Carracedo D, Paz Valiñas L, Tajes Alonso M, Triñanes Pego Y, Varela Reboiras L, Grupo de trabajo de la actualización de la Guía de Práctica Clínica sobre la Depresión Mayor en la Infancia y Adolescencia. Guía de Práctica Clínica sobre la Depresión Mayor en la Infancia y Adolescencia. Actualización. Ministerio de Sanidad Servicios Sociales e Igualdad, Unidad de Asesoramiento Científico-técnico. Avalía-t (eds.). 2018. Guías de Práctica Clínica en el SNS. DL: C 1950-20. https://portal.guiasalud.es/gpc/depresion-infancia/ Enlace
• Alvarez-Ariza M, Alvarez Garcia C, Atienza-Merino G, Basanta Matos R, Goicoechea-Castaño A, De-las-Heras-Liñero E, Mazaira Castro J, Montiel Carracedo D, Paz Valiñas L, Tajes Alonso M, Triñanes Pego Y, Varela Reboiras L, Grupo de trabajo de la actualización de la Guía de Práctica Clínica sobre la Depresión Mayor en la Infancia y Adolescencia. Guía de Práctica Clínica sobre la Depresión Mayor en la Infancia y Adolescencia. Actualización. Ministerio de Sanidad Servicios Sociales e Igualdad, Unidad de Asesoramiento Científico-técnico. Avalía-t (eds.). 2018. Guías de Práctica Clínica en el SNS. DL: C 1950-20. https://portal.guiasalud.es/gpc/depresion-infancia/ Enlace

Artigos Científicos

• Agís-Balboa RC, Pinheiro PS, Rebola N, Kerimoglu C, Benito E, Gertig M, Bahari-Javan S, Jain G, Burkhardt S, Delalle I, Jatzko A, Dettenhofer M, Zunszain PA, Schmitt A, Falkai P, Pape JC, Binder EB, Mulle C, Fischer A, Sananbenesi F. Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia. EMBO J. 2017 Oct;36(19):2815–28. PMID: 28768717. DOI: 10.15252/embj.201796821. IF2017: 10.557; D1. http://www.ncbi.nlm.nih.gov/pubmed/28768717 +Pubmed +DOI
• Álvarez-Payero M, Valeiras-Muñoz C, Lion-Vázquez S, Piñeiro-Corrales G, Muñoz-García D, Midaglia L. Experience with fampridine in clinical practice: analysis of a possible marker of clinical response. Int J Neurosci. 2017 Oct;127(10):915–22. PMID: 28054826. DOI: 10.1080/00207454.2017.1279614. IF2017: 1.848; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28054826 +Pubmed +DOI
• Amado A, Blanco MO, Repáraz-Andrade A. Spinocerebellar Ataxia 27: Clinical Phenotype of Twin Sisters with FGF14 Deletion. Neuropediatrics. 2017 Feb;48(2):131. PMID: 28192817. DOI: 10.1055/s-0037-1598110. IF2017: 1.605; Q3. http://www.ncbi.nlm.nih.gov/pubmed/28192817 +Pubmed +DOI
• Cabrerizo M, García-Iñiguez JP, Munell F, Amado A, Madurga-Revilla P, Rodrigo C, Pérez S, Martínez-Sapiña A, Antón A, Suárez G, Rabella N, Del Campo V, Otero A, Masa-Calles J. First Cases of Severe Flaccid Paralysis Associated With Enterovirus D68 Infection in Spain, 2015-2016. Pediatr Infect Dis J. 2017 Dec;36(12):1214–6. PMID: 28661963. DOI: 10.1097/INF.0000000000001668. IF2017: 2.305; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28661963 +Pubmed +DOI
• Crespo-Facorro B, Bernardo M, Argimon JM, Arrojo M, Bravo-Ortiz MF, Cabrera-Cifuentes A, Carretero-Román J, Franco-Martín MA, García-Portilla P, Haro JM, Olivares JM, Penadés R, Del Pino-Montes J, Sanjuán J, Arango C. Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project. Rev Psiquiatr Salud Ment. 2017 Jan;10(1):4–20. PMID: 27777062. DOI: 10.1016/j.rpsm.2016.09.001. IF2017: 2.233; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27777062 +Pubmed +DOI
• Cuadrado ML, Aledo-Serrano Á, Navarro P, López-Ruiz P, Fernández-de-Las-Peñas C, González-Suárez I, Orviz A, Fernández-Pérez C. Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial. Cephalalgia. 2017 Aug;37(9):864–72. PMID: 27296456. DOI: 10.1177/0333102416655159. IF2017: 3.886; Q1. http://www.ncbi.nlm.nih.gov/pubmed/27296456 +Pubmed +DOI
• Delgado-Morales R, Agís-Balboa RC, Esteller M, Berdasco M. Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders. Clin Epigenetics. 2017 Dec;9(1):67. PMID: 28670349. DOI: 10.1186/s13148-017-0365-z. IF2017: 6.091; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28670349 +Pubmed +DOI
• Fernandez O, Oterino A, Oreja-Guevara C, Prieto JM, Mendibe-Bilbao MM, Garcia-Merino JA, Ramio-Torrenta L, Ginestal R, Meca-Lallana JE, Romero-Pinel L, Munoz D, Oliva-Nacarino P, Calles-Hernandez MC, Izquierdo G, Martinez-Gines ML, Saiz A, Comabella M, Casanova-Estruch B, Brieva L, Arroyo R, Rodriguez-Antiguedad A. Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (I). Rev Neurol. 2017 Jul;65(1):31–40. PMID: 28650065. IF2017: 0.601; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28650065 +Pubmed
• Fernandez O, Oterino A, Oreja-Guevara C, Prieto JM, Mendibe-Bilbao MM, Garcia-Merino JA, Ramio-Torrenta L, Ginestal R, Meca-Lallana JE, Romero-Pinel L, Munoz D, Oliva-Nacarino P, Calles-Hernandez MC, Izquierdo G, Martinez-Gines ML, Saiz A, Comabella M, Casanova-Estruch B, Brieva L, Arroyo R, Rodriguez-Antiguedad A. Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (II). Rev Neurol. 2017 Jul;65(2):75–84. PMID: 28675259. IF2017: 0.601; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28675259 +Pubmed
• Fuku N, Díaz-Peña R, Arai Y, Abe Y, Zempo H, Naito H, Murakami H, Miyachi M, Spuch C, Serra-Rexach JA, Emanuele E, Hirose N, Lucia A. Epistasis, physical capacity-related genes and exceptional longevity: FNDC5 gene interactions with candidate genes FOXOA3 and APOE. BMC Genomics. 2017 Nov;18(Suppl 8):803. PMID: 29143599. DOI: 10.1186/s12864-017-4194-4. IF2017: 3.730; Q1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688477/pdf/12864_2017_Article_4194.pdf +Pubmed +DOI
• González-Suárez I, Ríos-Blanco JJ, Arpa J. Accelerated atherosclerosis in ANCA-associated vasculitis. Acta Neurol Scand. 2017 Dec;136(6):688–93. PMID: 28608454. DOI: 10.1111/ane.12787. IF2017: 3.126; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28608454 +Pubmed +DOI
• González-Suarez I, Rodríguez de Antonio L, Orviz A, Moreno-García S, Valle-Arcos MD, Matias-Guiu JA, Valencia C, Jorquera Moya M, Oreja-Guevara C. Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation. Brain Behav. 2017 Apr;7(4):e00671. PMID: 28413713. DOI: 10.1002/brb3.671. IF2017: 2.219; Q3. http://www.ncbi.nlm.nih.gov/pubmed/28413713 +Pubmed +DOI
• Kerimoglu C, Sakib MS, Jain G, Benito E, Burkhardt S, Capece V, Kaurani L, Halder R, Agís-Balboa RC, Stilling R, Urbanke H, Kranz A, Stewart AF, Fischer A. KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. Cell Rep. 2017 Jul;20(3):538–48. PMID: 28723559. DOI: 10.1016/j.celrep.2017.06.072. IF2017: 8.032; D1. http://www.ncbi.nlm.nih.gov/pubmed/28723559 +Pubmed +DOI
• Oreja-Guevara C, Gómez-Pinedo U, García-López J, Sánchez-Sánchez R, Valverde-Moyano R, Rabano-Gutierrez A, Matías-Guiu JA, González-Suárez I, Matías-Guiu J. Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis. Mult Scler Relat Disord. 2017 Nov;18:71–6. PMID: 29141824. DOI: 10.1016/j.msard.2017.09.024. IF2017: 3.199; Q2. http://www.ncbi.nlm.nih.gov/pubmed/29141824 +Pubmed +DOI
• Pérez V, Salavert A, Espadaler J, Tuson M, Saiz-Ruiz J, Sáez-Navarro C, Bobes J, Baca-García E, Vieta E, Olivares JM, Rodriguez-Jimenez R, Villagrán JM, Gascón J, Cañete-Crespillo J, Solé M, Saiz PA, Ibáñez Á, de Diego-Adeliño J, AB-GEN Collaborative Group, Menchón JM. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial. BMC Psychiatry. 2017 Dec;17(1):250. PMID: 28705252. DOI: 10.1186/s12888-017-1412-1. IF2017: 2.419; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28705252 +Pubmed +DOI
• Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, Martinez-Lapiscina EH, Green AJ, Kardon R, Outteryck O, Paul F, Schippling S, Vermersch P, Villoslada P, Balk LJ, ERN-EYE IMSVISUAL. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2017;16(10):797–812. PMID: 28920886. DOI: 10.1016/S1474-4422(17)30278-8. http://www.ncbi.nlm.nih.gov/pubmed/28920886 +Pubmed +DOI
• Rivas L, Blanco Ó, Torreira C, Repáraz A, Melcón C, Amado A. [Pontocerebellar hypoplasia secondary to CASK gene deletion: Case report]. Rev Chil Pediatr. 2017;88(4):529–33. PMID: 28898323. DOI: 10.4067/S0370-41062017000400014. IF2017: N/A. http://www.ncbi.nlm.nih.gov/pubmed/28898323 +Pubmed +DOI
• Rodrigues-Amorim D, Rivera-Baltanás T, López M, Spuch C, Olivares JM, Agís-Balboa RC. Schizophrenia: A review of potential biomarkers. J Psychiatr Res. 2017 Oct;93:37–49. PMID: 28578207. DOI: 10.1016/j.jpsychires.2017.05.009. IF2017: 4.000; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28578207 +Pubmed +DOI
• Romay-Tallon R, Rivera-Baltanas T, Allen J, Olivares JM, Kalynchuk LE, Caruncho HJ. Comparative study of two protocols for quantitative image-analysis of serotonin transporter clustering in lymphocytes, a putative biomarker of therapeutic efficacy in major depression. Biomark Res. 2017 Dec;5(1):27. PMID: 29018523. DOI: 10.1186/s40364-017-0107-6. IF2017: N/A. http://www.ncbi.nlm.nih.gov/pubmed/29018523 +Pubmed +DOI
• Tomas-Roig J, Benito E, Agis-Balboa RC, Piscitelli F, Hoyer-Fender S, Di Marzo V, Havemann-Reinecke U. Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice. Addict Biol. 2017 Nov;22(6):1778–89. PMID: 27578457. DOI: 10.1111/adb.12446. IF2017: 5.578; D1. http://www.ncbi.nlm.nih.gov/pubmed/27578457 +Pubmed +DOI
• Vázquez Campo M, Diéguez Álvarez J, García-Caballero A. Sesgo “salto a las conclusiones” en pacientes con patología psiquiátrica. Metas de enfermería. 2017;20(6):67–73. IF2017: N/A. https://dialnet.unirioja.es/servlet/articulo?codigo=6082127 Enlace

Guías de Práctica

• Álvarez-Ariza M, Goicoechea-Castano A. Fisterra Guías Clínicas: Somatizaciones en Pediatría. 2017. https://www.fisterra.com/guias-clinicas/somatizaciones-pediatria/#27110 Enlace

Artigos Científicos

• Barrio-Alonso M, Conejero-Gómez R, Craven-Bartle Coll A, Martín-Cañuelo J, García-Turrillo E, Laxe-García S, Morales-Mateu A, Torrequebrada-Giménez A, Benito-Penalva J, Cívicos-Sánchez N, Jauregui-Abrisqueta ML, Montoto-Marqués A, Juan-García FJ, Rodríguez-Piñero M. Consenso sobre la profilaxis y tratamiento de la enfermedad tromboembólica venosa en la lesión medular y en el daño cerebral adquirido. Angiologia. 2016 May;68(3):227–34. DOI: 10.1016/j.angio.2015.10.013. IF2016: N/A. http://linkinghub.elsevier.com/retrieve/pii/S0003317015002217 +DOI
• Blanco-Barca Ó, Amado-Puentes A, Repáraz A, Melcón C, Torreira C. [Spinocerebellar ataxia-27: description of the clinical phenotype of two twin sisters with a deletion in the FGF14 gene]. Rev Neurol. 2016 Mar;62(5):238–9. PMID: 26916329. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/26916329 +Pubmed
• Caruncho HJ, Brymer K, Romay-Tallón R, Mitchell MA, Rivera-Baltanás T, Botterill J, Olivares JM, Kalynchuk LE. Reelin-Related Disturbances in Depression: Implications for Translational Studies. Front Cell Neurosci. 2016 Feb;10:48. PMID: 26941609. DOI: 10.3389/fncel.2016.00048. IF2016: 4.555; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26941609 +Pubmed +DOI
• Costa-Arpín E, Pato A, Rodríguez-Regal A, Midaglia L, Yáñez R, Muñoz D, Lorenzo JR, Amigo C, Prieto JM. Clinical response and tolerability of fampridine in clinical practice. Neurodegener Dis Manag. 2016 Apr;6(2):99–105. PMID: 27032814. DOI: 10.2217/nmt-2015-0004. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27032814 +Pubmed +DOI
• Fernández O, Arroyo R, Martínez-Yélamos S, Marco M, Merino JAG, Muñoz-García D, Merino E, Roque A, Group RS. Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis. Infante-Duarte C (ed.). PLoS One. 2016 Aug;11(8):e0160313. PMID: 27526201. DOI: 10.1371/journal.pone.0160313. IF2016: 2.806; Q1. http://www.ncbi.nlm.nih.gov/pubmed/27526201 +Pubmed +DOI
• Fernandez O, Rodriguez-Antiguedad A, Olascoaga J, Oreja-Guevara C, Prieto JM, Mendibe-Bilbao MM, Garcia-Merino JA, Ramio-Torrenta L, Ginestal R, Meca-Lallana JE, Romero-Pinel L, Munoz D, Saiz A, Calles-Hernandez MC, Izquierdo G, Villar LM, Oliva-Nacarino P, Arnal-Garcia C, Comabella M, Brieva L, Arroyo R, Montalban X. Review of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meeting. Rev Neurol. 2016 Jun;62(12):559–69. PMID: 27270678. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27270678 +Pubmed
• Fernández-Martínez R, Kokoulina E, Carballido-Araujo E, Garcia-Fuertes I, Gutierrez-Martinez O, Santiago-Lopez F, Vazquez-Batan P. [Clinical usefulness and psychometric properties of the Cambridge Behavioural Inventory]. Rev Neurol. 2016 Nov;63(10):440–6. PMID: 27819401. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27819401 +Pubmed
• Garcia-Dominguez JM, Muñoz D, Comellas M, Gonzalbo I, Lizán L, Polanco Sánchez C. Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment. Patient Prefer Adherence. 2016 Sep;10:1945–56. PMID: 27713622. DOI: 10.2147/PPA.S114619. IF2016: 1.798; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27713622 +Pubmed +DOI
• Guijarro-Castro C, Sanchez-Zapardiel E, Munoz D, Fernandez O, Leyva L, Castro-Panete MJ, Picon-Munoz C, Talise M, Martinez-Feito A, Paz-Artal E. Month of birth, HLA-DRB1*15 locus and risk of multiple sclerosis in offspring. Rev Neurol. 2016 Sep;63(5):201–5. PMID: 27569565. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27569565 +Pubmed
• Lo TL, Warden M, He Y, Si T, Kalyanasundaram S, Thirunavukarasu M, Amir N, Hatim A, Bautista T, Lee C, Emsley R, Olivares J, Yang YK, Kongsakon R, Castle D. Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region. Asia Pac Psychiatry. 2016 Jun;8(2):154–71. PMID: 27062665. DOI: 10.1111/appy.12234. IF2016: 0.954; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27062665 +Pubmed +DOI
• Lopez de Munain L, Juan-Garcia FJ, Duarte E, Martin-Mourelle R, Rodriguez S, Moraleda-Perez S. [Early pharmacologic treatment with botulinum toxin A in post-stroke spasticity: consensus evidence-based recommendations]. Rev Neurol. 2016 Oct;63(8):363–9. PMID: 27699753. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27699753 +Pubmed
• López-Cortés R, Formigo J, Reboiro-Jato M, Fdez-Riverola F, Blanco FJ, Lodeiro C, Oliveira E, Capelo JL, Santos HM. A methodological approach based on gold-nanoparticles followed by matrix assisted laser desorption ionization time of flight mass spectrometry for the analysis of urine profiling of knee osteoarthritis. Talanta. 2016 Apr;150:638–45. PMID: 26838453. DOI: 10.1016/j.talanta.2015.06.043. IF2016: 4.162; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26838453 +Pubmed +DOI
• Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller A-K, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P, IMSVISUAL consortium. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol. 2016 May;15(6):574–84. PMID: 27011339. DOI: 10.1016/S1474-4422(16)00068-5. IF2016: 26.284; D1. http://www.ncbi.nlm.nih.gov/pubmed/27011339 +Pubmed +DOI
• Meca-Lallana J, Hernández L, Caminero AB, Girón JM, Cano-Orgaz A, Carcelén-Gadea M, Muñoz D, Durán-Ferreras E, Martín-Hernández J, Sánchez-de la Rosa R, FATIGA Study Group. Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-? to Glatiramer Acetate in Clinical Practice. Eur Neurol. 2016;76(1–2):40–7. PMID: 27376845. DOI: 10.1159/000447630. IF2016: 1.697; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27376845 +Pubmed +DOI
• Pato-Pato A, Midaglia L, Costa-Arpin E, Rodriguez-Regal A, Puy-Nunez A, Rodriguez-Rodriguez M, Lopez-Real A, Llaneza-Gonzalez MA, Garcia-Estevez DA, Moreno-Carretero MJ, Escriche-Jaime D, Aguado-Valcarcel ML, Munoz D, Prieto JM, Lorenzo-Gonzalez JR, Amigo-Jorrin MC. [Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia]. Rev Neurol. 2016 Sep;63(s01):S13–8. PMID: 27658431. IF2016: 0.743; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27658431 +Pubmed
• Sepúlveda M, Armangue T, Martinez-Hernandez E, Arrambide G, Sola-Valls N, Sabater L, Téllez N, Midaglia L, Ariño H, Peschl P, Reindl M, Rovira A, Montalban X, Blanco Y, Dalmau J, Graus F, Saiz A. Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes. J Neurol. 2016 Jul;263(7):1349–60. PMID: 27147513. DOI: 10.1007/s00415-016-8147-7. IF2016: 3.389; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27147513 +Pubmed +DOI
• Triñanes Y, Atienza G, Rial-Boubeta A, Calderón-Gómez C, Álvarez-Ariza M, De-Las-Heras-Liñero E, López-García M. [Areas for improvement in the management of depression: perspectives of patients, families and professionals]. Rev Calid Asist. 2016 Dec;31(6):365–72. PMID: 27316547. DOI: 10.1016/j.cali.2016.03.010. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27316547 +Pubmed +DOI
• Vázquez-Campo M, Maroño Y, Lahera G, Mateos R, García-Caballero A. e-Motional Training®: Pilot study on a novel online training program on social cognition for patients with schizophrenia. Schizophr Res Cogn. The Authors; 2016 Jun;4:10–7. PMID: 28740808. DOI: 10.1016/j.scog.2015.11.007. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/28740808 +Pubmed +DOI
• Villar-Quiles RN, Matías-Guiu JA, Ortega G, González-Suárez I, Oreja-Guevara C, Matías-Guiu J. Analysis of the Relationship between the Month of Birth and Risk of Multiple Sclerosis in a Spanish Population. Eur Neurol. 2016;76(5–6):202–9. PMID: 27721317. DOI: 10.1159/000449246. http://www.ncbi.nlm.nih.gov/pubmed/27721317 +Pubmed +DOI

Artigos Científicos

• Álvarez E, Olivares JM, Carrasco JL, López-Gómez V, Rejas J. Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors. Ann Gen Psychiatry. 2015 Jan;14(1):2. PMID: 25632294. DOI: 10.1186/s12991-014-0040-0. IF2015: 1.411; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25632294 +Pubmed +DOI
• Emsley R, Alptekin K, Azorin J-M, Cañas F, Dubois V, Gorwood P, Haddad PM, Naber D, Olivares-Díez JM, Papageorgiou G, Roca M, Thomas P, Hargarter L, Schreiner A, EMEA ADHES Group. Nurses´ perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey. Ther Adv Psychopharmacol. 2015 Dec;5(6):339–50. PMID: 26834967. DOI: 10.1177/2045125315612013. IF2015: N/A. http://www.ncbi.nlm.nih.gov/pubmed/26834967 +Pubmed +DOI
• Fernández Fernández MA, Amado Puentes A. [The importance of being careful with the concepts on autism spectrum disorders]. An Pediatr (Barc). 2015 May;82(5):372. PMID: 25510842. DOI: 10.1016/j.anpedi.2014.09.016. IF2015: 0.773; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25510842 +Pubmed +DOI
• Fernandez O, Alvarez-Cermeno JC, Arroyo R, Brieva L, Calles-Hernandez MC, Casanova-Estruch B, Comabella M, Garcia-Merino JA, Ginestal R, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao MM, Montalban X, Munoz-Garcia D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Ramio-Torrenta L, Romero-Pinel L, Rodriguez-Antiguedad A, Saiz A, Tintore M, Grupo Post-Ectrims GP-E. Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II). Rev Neurol. 2015 Sep;61(6):271–83. PMID: 26350778. IF2015: 0.684; Q4. http://www.ncbi.nlm.nih.gov/pubmed/26350778 +Pubmed
• Fernandez O, Alvarez-Cermeno JC, Arroyo R, Brieva L, Calles-Hernandez MC, Casanova-Estruch B, Comabella M, Garcia-Merino JA, Ginestal R, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao MM, Montalban X, Munoz-Garcia D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Ramio-Torrenta L, Romero-Pinel L, Rodriguez-Antiguedad A, Saiz A, Tintore M, Grupo Post-Ectrims. [Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)]. Rev Neurol. 2015 Sep;61(5):215–24. PMID: 26308843. IF2015: 0.684; Q4. http://www.ncbi.nlm.nih.gov/pubmed/26308843 +Pubmed
• Fernández-Cabanaa M, Jiménez-Féliz J, Alves-Pérez MT, Mateos R, Gómez-Reino I, García-Caballero A. Linguistic analysis of suicide notes in Spain. Eur J Psychiatry. University of Zaragoza; 2015;29(2):145–55. IF2015: 0.711; Q4. http://dialnet.unirioja.es/servlet/articulo?codigo=5171234 Enlace
• Flórez G, Casas A, Kreis MKF, Forti L, Martínez J, Fernández J, Conde M, Vázquez-Noguerol R, Blanco T, Hoff HA, Cooke DJ. A Prototypicality Validation of the Comprehensive Assessment of Psychopathic Personality (CAPP) Model Spanish Version. J Pers Disord. 2015 Oct;29(5):707–18. PMID: 25248021. DOI: 10.1521/pedi_2014_28_167. IF2015: 3.515; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25248021 +Pubmed +DOI
• Muñoz-García D, Midaglia L, Martinez Vilela J, Marín Sánchez M, López González FJ, Arias Gómez M, Dapena Bolaño D, Iglesias Castañón A, Alonso Alonso M, Romero López J. Associated Inosine to interferon: results of a clinical trial in multiple sclerosis. Acta Neurol Scand. 2015 Jun;131(6):405–10. PMID: 25313094. DOI: 10.1111/ane.12333. IF2015: 5.559; Q2. http://www.ncbi.nlm.nih.gov/pubmed/25313094 +Pubmed +DOI
• Olivares JM, Álvarez E, Carrasco JL, Pérez Páramo M, López-Gómez V. Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms. Int Clin Psychopharmacol. 2015 Sep;30(5):265–71. PMID: 26111356. DOI: 10.1097/YIC.0000000000000087. IF2015: 2.415; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26111356 +Pubmed +DOI
• Rivera-Baltanas T, Agis-Balboa RC, Romay-Tallon R, Kalynchuk LE, Olivares-Díez JM, Caruncho HJ. Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naïve depressive patients treated with antidepressant medication. Ann Gen Psychiatry. 2015 Dec;14(1):45. PMID: 26697099. DOI: 10.1186/s12991-015-0085-8. IF2015: 1.411; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26697099 +Pubmed +DOI
• Romay-Tallon R, Rivera-Baltanas T, Kalynchuk LE, Caruncho HJ. Differential effects of corticosterone on the colocalization of reelin and neuronal nitric oxide synthase in the adult hippocampus in wild type and heterozygous reeler mice. Brain Res. 2015 Jan;1594:274–83. PMID: 25451109. DOI: 10.1016/j.brainres.2014.10.050. IF2015: 2.561; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25451109 +Pubmed +DOI
• Ruiz MA, Álvarez E, Carrasco JL, Olivares-Díez JM, Pérez M, Rejas J. Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice. Drug Des Devel Ther. 2015 Aug;9(7):4329–40. PMID: 26273194. DOI: 10.2147/DDDT.S88238. IF2015: 2.881; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26273194 +Pubmed +DOI
• Spuch C, Antequera D, Pascual C, Abilleira S, Blanco M, Moreno-Carretero MJ, Romero-López J, Ishida T, Molina JA, Villarejo A, Bermejo-Pareja F, Carro E. Soluble Megalin is Reduced in Cerebrospinal Fluid Samples of Alzheimer´s Disease Patients. Front Cell Neurosci. 2015 Apr;9:134. PMID: 25926771. DOI: 10.3389/fncel.2015.00134. IF2015: 4.609; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25926771 +Pubmed +DOI
• Triñanes Y, Atienza G, Louro-González A, De-las-Heras-Liñero E, Alvarez-Ariza M, Palao DJ. Development and impact of computerised decision support systems for clinical management of depression: A systematic review. Rev Psiquiatr y salud Ment. 2015 Jul;8(3):157–66. PMID: 25500093. DOI: 10.1016/j.rpsm.2014.10.004. IF2015: 1.65; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25500093 +Pubmed +DOI
• Villoslada P, Rovira A, Montalban X, Arroyo R, Paul F, Meca-Lallana V, Ramo C, Fernandez O, Saiz A, Garcia-Merino A, Ramió-Torrentà L, Casanova B, Oreja-Guevara C, Muñoz-García D, Martinez-Rodriguez JE, Lensch E, Prieto JM, Meuth SG, Nuñez X, Campás C, Pugliese M, Study N. Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial. Neurol Neuroimmunol neuroinflammation. 2015 Oct;2(5):e147. PMID: 26405686. DOI: 10.1212/NXI.0000000000000147. IF2015: N/A. http://www.ncbi.nlm.nih.gov/pubmed/26405686 +Pubmed +DOI

Artigos Científicos

• Agbemenyah HY, Agis-Balboa RC, Burkhardt S, Delalle I, Fischer A. Insulin growth factor binding protein 7 is a novel target to treat dementia. Neurobiol Dis. 2014 Feb;62:135–43. PMID: 24075854. DOI: 10.1016/j.nbd.2013.09.011. IF: 5.078; Q1. http://www.ncbi.nlm.nih.gov/pubmed/?term=24075854 +Pubmed +DOI
• Agis-Balboa RC, Fischer A. Generating new neurons to circumvent your fears: the role of IGF signaling. Cell Mol Life Sci. 2014 Jan;71(1):21–42. PMID: 23543251. DOI: 10.1007/s00018-013-1316-2. IF: 5.808; Q1. http://www.ncbi.nlm.nih.gov/pubmed/?term=23543251 +Pubmed +DOI
• Agis-Balboa RC, Guidotti A, Pinna G. 5alpha-reductase type I expression is downregulated in the prefrontal cortex/Brodmann´s area 9 (BA9) of depressed patients. Psychopharmacology (Berl). 2014 Sep;231(17):3569–80. PMID: 24781515. DOI: 10.1007/s00213-014-3567-5. IF: 3.875; Q1. http://www.ncbi.nlm.nih.gov/pubmed/?term=24781515 +Pubmed +DOI
• Álvarez-Payero M, Martínez López de Castro N, Ucha Samartín M, Martín Vila A, Vázquez López C, Piñeiro Corrales G. Medication non-adherence as a cause of hospital admissions. Farm Hosp. 2014 Jul;38(4):328–33. PMID: 25137166. DOI: 10.7399/fh.2014.38.4.7660. IF: N/A. http://www.ncbi.nlm.nih.gov/pubmed/?term=25137166 +Pubmed +DOI
• Amado-Puentes A, Blanco-Barca Ó, Coll MJ, Sobrido MJ. [Disease due to lysosomal deposits with differential peculiarities: type II GM1 gangliosidosis]. Rev Neurol. 2014 Apr;58(8):382–3. PMID: 24723181. IF: 0.83; Q4. http://www.ncbi.nlm.nih.gov/pubmed/24723181 +Pubmed
• Fernandez O, Alvarez-Cermeno JC, Arnal-Garcia C, Arroyo-Gonzalez R, Brieva L, Calles-Hernandez MC, Casanova-Estruch B, Comabella M, Garcia-Merino JA, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao MM, Munoz-Garcia D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Prieto JM, Ramio-Torrenta L, Romero-Pinel L, Saiz A, Rodriguez-Antiguedad A, Grupo Post-Ectrims GP-E. Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I). Rev Neurol. 2014 Sep;59(6):269–80. PMID: 25190340. IF: 0.830; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25190340 +Pubmed
• Fernández Ó, Álvarez-Cermeño JC, Arnal-García C, Arroyo-González R, Brieva L, Calles-Hernández MC, Casanova-Estruch B, Comabella M, García-Merino JA, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao M del M, Muñoz-García D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Prieto JM, Ramió-Torrentà L, Romero-Pinel L, Saiz A, Rodríguez-Antigüedad A, Grupo Post-ECTRIMS. Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III). Rev Neurol. 2014 Oct;59(8):371–9. PMID: 25297480. IF: 0.830; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25297480 +Pubmed
• Fernández Ó, Álvarez-Cermeño JC, Arnal-García C, Arroyo-González R, Brieva L, Calles-Hernández MC, Casanova-Estruch B, Comabella M, García-Merino JA, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao M del M, Muñoz-García D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Prieto JM, Ramió-Torrentà L, Romero-Pinel L, Saiz A, Rodríguez-Antigüedad A, Grupo Post-ECTRIMS. Revisión de las novedades presentadas en el XXIX Congreso del Comité Europeo para el Tratamiento e Investigación en Esclerosis Múltiple (ECTRIMS) (II). Rev Neurol. 2014 Oct;59(7):307–16. PMID: 25245875. IF: 0.830; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25245875 +Pubmed
• González-Suárez I, Aguilar-Amat MJ, Trigueros M, Borobia AM, Cruz A, Arpa J. Leukoencephalopathy due to oral methotrexate. Cerebellum. 2014 Feb;13(1):178–83. PMID: 24068485. DOI: 10.1007/s12311-013-0528-1. IF2014: 2.717; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24068485 +Pubmed +DOI
• Kokoulina E, Fernández R. Maltrato físico y emocional en la infancia y conducta suicida en el adulto. Rev Psicopatología y Psicol Clínica. 2014 Aug;19(2):93–103. DOI: 10.5944/rppc.vol.19.num.2.2014.13060. IF: N/A. http://dialnet.unirioja.es/servlet/extart?codigo=4829647 +DOI
• López Fernández JC, Masjuan Vallejo J, Arenillas Lara J, Blanco González M, Botia Paniagua E, Casado Naranjo I, Deyá Arbona E, Escribano Soriano B, Freijo Guerrero MM, Fuentes B, Gállego Cullere J, Geffners Sclarskyi D, Gil Núñez A, Gómez Escalonilla C, Lago Martin A, Legarda Ramírez I, Maciñeiras Montero JL, Maestre Moreno J, Moniche Álvarez F, Muñoz Arrondo R, Purroy García F, Ramírez Moreno JM, Rebollo Álvarez Amandix M, Roquer J, Rubio Borrego F, Segura T, Serrano Ponza M, Tejada García J, Tejero Juste C, Vidal Sánchez JA. Análisis de recursos asistenciales para el ictus en España en 2012: ¿beneficios de la Estrategia del Ictus del Sistema Nacional de Salud?. Neurol (Barcelona, Spain). 2014 Sep;29(7):387–96. PMID: 24035294. DOI: 10.1016/j.nrl.2013.06.017. IF: 1.381; Q4. http://www.ncbi.nlm.nih.gov/pubmed/24035294 +Pubmed +DOI
• Lopez M, Olivares JM, Berrios GE. Pellagra encephalopathy in the context of alcoholism: review and case report. Alcohol Alcohol. 2014 Jan;49(1):38–41. PMID: 23926211. DOI: 10.1093/alcalc/agt070. IF: 2.889; Q1. http://www.ncbi.nlm.nih.gov/pubmed/?term=23926211 +Pubmed +DOI
• Midaglia L, Dieguez-Varela C, Banegas S, Campos-García S, Muñoz-García D. Buscando una herramienta para la detección precoz de deterioro cognitivo en esclerosis múltiple [Looking for a tool for early detection of cognitive impairment in multiple sclerosis]. Rev Española Investig Oftalmológicas. 2014 Mar;4(1):3–7. IF: N/A. http://www.arke144.com/reiof-2014-vol-4-n-1.html Enlace
• Midaglia L, Pato-Pato A, Rodriguez-Constenla I, Santos-Armentia E, Cimas-Hernando I, Lopez-Fernandez M, Munoz-Garcia D, Valeiras-Munoz C, Lorenzo-Gonzalez JR. Paraparesia espástica tropical: un informe de un nuevo caso en España [Tropical spastic paraparesis: a report of a new case in Spain]. Rev Neurol. 2014 Jun;58(12):573–5. PMID: 24915034. IF: 0.830; Q4. http://www.ncbi.nlm.nih.gov/pubmed/24915034 +Pubmed
• Ortolano S, Vieitez I, Agis-Balboa RC, Spuch C. Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease. Mol Brain. 2014 Jan;7:7. PMID: 24472629. DOI: 10.1186/1756-6606-7-7. IF: 4.902; Q1. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3917365&tool=pmcentrez&rendertype=abstract +Pubmed +DOI
• Ortolano S, Viéitez I, Navarro C, Spuch C. Treatment of lysosomal storage diseases: recent patents and future strategies. Recent Pat Endocr Metab Immune Drug Discov. 2014 Jan;8(1):9–25. PMID: 24433521. IF: N/A. http://www.ncbi.nlm.nih.gov/pubmed/24433521 +Pubmed
• Piñeiro Corrales G, Vazquez Lopez C, Álvarez-Payero M, Vázquez López C, Álvarez Payero M. Efecto del tratamiento farmacológico en el estado nutricional del paciente neurológico [Effect of pharmacologic treatment of the nutritional status of neurologic patients]. Nutr Hosp. 2014 Jan;29 Suppl 2:47–56. PMID: 25077345. IF: 1.040; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25077345 +Pubmed
• Rivera-Baltanas T, Olivares JM, Martinez-Villamarin JR, Fenton EY, Kalynchuk LE, Caruncho HJ. Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy. J Affect Disord. 2014 Jul;163:47–55. PMID: 24836087. DOI: 10.1016/j.jad.2014.03.011. IF: 3.383; Q2. http://www.ncbi.nlm.nih.gov/pubmed/?term=24836087 +Pubmed +DOI

Capítulos de libro

• Fernández Hierro J, Gómez Conde L, Muñoz Rodríguez K. Delirios. In: Rodríguez Cerdeira C (ed.). Manejo clínico de la Psicodermatología (Tomo 1). 1st ed. Editorial Círculo Rojo; 2014. ISBN: 978-84-9076-924-9. http://editorialcirculorojo.com/manejo-clinico-de-la-psicodermatologia/ Enlace
• Fernández Hierro J, Gómez Conde L, Muñoz Rodríguez K. Delirios. In: Rodríguez Cerdeira C (ed.). Manejo clínico de la Psicodermatología (Tomo 1). 1st ed. Editorial Círculo Rojo; 2014. ISBN: 978-84-9076-924-9. http://editorialcirculorojo.com/manejo-clinico-de-la-psicodermatologia/ Enlace
• Triñanes Pego Y, Boubeta Rial A, Álvarez Ariza M, De-las-Heras-Liñero E, Atienza Merino G, López García M. ¿Cómo mejorar la práctica clínica de la depresión?: una aproximación cualitativa [How to improve the management of depression?: a qualitative approach]. Ministerio de Sanidad, Servicios Sociales e Igualdad. Santiago de Compostela: Consellería de Sanidad, Axencia de Avaliación de Tecnoloxías Sanitarias de Galicia (avalia-t); 2014. http://www.sergas.es/Docs/Avalia-t/avalia_t201404CualitativaDepresion.def.pdf Enlace

Guías de Práctica

• Álvarez Ariza M, Atienza Merino G, Ávila González M, González García A, Guitián Rodríguez D, Grupo de trabajo de la Guía de Práctica Clínica sobre el Manejo de la Depresión en el Adulto. Guía de práctica clínica sobre el manejo de la depresión en el adulto. Ministerio de Sanidad, Servicios Sociales e Igualdad. Agencia de Evaluación de Tecnologías Sanitarias de Galicia (avalia-t); 2014. Guías de Práctica Clínica en el SNS: Avalia-t 2013. ISBN: 44444-44444. http://www.sergas.es/Docs/Avalia-t/avalia_t201306GPCdepresion_adulto.pdf Enlace
• Louro González A, De-las-Heras-Liñero E, Atienza Merino G, Triñanes Pego Y, Álvarez Ariza M, González García A, Guitián Rodríguez D, Miembros del Grupo de Trabajo de la GPC sobre el Manejo de la Depresión en el Adulto. Servizo Galego de Saúde. Adaptaciones de la GPC sobre el manejo de la Depresion en el Adulto: Factores de riesgo y diagnóstico. 2014. Revisión 2014. http://www.fisterra.com/guias-clinicas/depresion-adulto/ Enlace
• Louro González A, De-las-Heras-Liñero E, Atienza Merino G, Triñanes Pego Y, Álvarez Ariza M, González García A, Guitián Rodríguez D, Miembros del Grupo de Trabajo de la GPC sobre el Manejo de la Depresión en el Adulto. Servizo Galego de Saúde. Guía clínica de Depresión mayor en el adulto: Medidas generales y tratamiento farmacológico. 2014. Revisión: 2014. https://www.fisterra.com/guias-clinicas/depresion-mayor-adulto-medidas-generales-tratamiento-farmacologico/ Enlace
• Louro González A, De-las-Heras-Liñero E, Atienza Merino G, Triñanes Pego Y, Álvarez Ariza M, González García A, Guitián Rodríguez D, Miembros del Grupo de Trabajo de la GPC sobre el Manejo de la Depresión en el Adulto. Servizo Galego de Saúde. Guía clínica de Depresión mayor en el adulto: psicoterapia y otros tratamientos no farmacológicos. 2014. Revisión 2014. https://www.fisterra.com/guias-clinicas/depresion-mayor-adulto-psicoterapia-otros-tratamientos-no-farmacologicos/ Enlace